Cargando…
Platelet-Derived Procoagulant Microparticles as Blood-based Biomarker of Breast Cancer
OBJECTIVE: Breast cancer is the main cause of cancer death in women worldwide. Elevated plasma levels of circulating cell-derived microparticles (MPs) have been reported in various types of cancer, including breast cancer, with the ability to mediate inflammation and thrombosis. Microparticles are b...
Autores principales: | Haghbeen, Marzieh, Hashemi Tayer, Akbar, Kamravan, Maryam, Sotoodeh Jahromi, Abdolreza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408375/ https://www.ncbi.nlm.nih.gov/pubmed/34048188 http://dx.doi.org/10.31557/APJCP.2021.22.5.1573 |
Ejemplares similares
-
Association of Circulating Procoagulant Microvesicles with Painful Vaso-Occlusive Crisis in Sickle Cell Disease
por: Hashemi Tayer, Akbar, et al.
Publicado: (2023) -
Comparison of Interleukin-33 Serum Levels in Patients with Breast Cancer and Idiopathic Granulomatous Mastitis
por: Haghbin, Marzieh, et al.
Publicado: (2023) -
Toxicity of Saffron Extracts on Cancer and Normal Cells: A Review Article
por: Shakeri, Masihollah, et al.
Publicado: (2020) -
Clinical significance of procoagulant microparticles
por: Nomura, Shosaku, et al.
Publicado: (2015) -
Phosphatidylserine exposing-platelets and microparticles promote procoagulant activity in colon cancer patients
por: Zhao, Liangliang, et al.
Publicado: (2016)